Jasper Therapeutics Inc
NASDAQ:JSPR
Jasper Therapeutics Inc
NASDAQ:JSPR
Price:
1.44
USD
-2.04%
Market Closed
Market Cap:
$40.3m
Relative Value
There is not enough data to reliably calculate the relative value of JSPR.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
JSPR
Relative Value
Base Case
Not Available
Multiples Across Competitors
JSPR Competitors Multiples
Jasper Therapeutics Inc Competitors
Jasper Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Jasper Therapeutics Inc
NASDAQ:JSPR
|
40.3m USD | 0 | -0.4 | 0.1 | 0.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
383.2B USD | 6.4 | 163.2 | 15.9 | 22.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.2B USD | 5.5 | 28.2 | 19.9 | 19.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
181.9B USD | 6.2 | 22.4 | 15.2 | 15.2 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
119.9B USD | 10.2 | 32.7 | 24 | 25.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.7B USD | 5.7 | 18.1 | 15.4 | 17.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
87.9B AUD | 3.9 | 20.4 | 13.6 | 17 | |
| NL |
|
argenx SE
XBRU:ARGX
|
44.4B EUR | 14.5 | 34.1 | 58.2 | 59.8 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
